Dan Puckett, Chief Financial Officer at Shockwave Medical, Inc. (SWAV), sold 9,656 shares at $229.27 ($2.2M) on 2024-02-05, disclosed to the SEC on 2024-02-06.
Scheduled sale ($2.2M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $226.29 | 1,077 | $244K | 11.0% |
| 2 | $226.29 | 2,208 | $500K | 22.6% |
| 3 | $226.32 | 213 | $48K | 2.2% |
| 4 | $229.27 | 300 | $69K | 3.1% |
| 5 | $230.99 | 1,703 | $393K | 17.8% |
| 6 | $230.99 | 1,703 |
| $393K |
| 17.8% |
| 7 | $231.84 | 1,226 | $284K | 12.8% |
| 8 | $231.84 | 1,226 | $284K | 12.8% |
| Total | $229.45 avg | 9,656 | $2.2M | 100% |
| Filing → |
| SWAV | SELL | 2023-05-12 | $1.2M | — | Filing → |
| SWAV | SELL | 2023-04-19 | $530K | — | Filing → |
| SWAV | SELL | 2023-03-22 | $221K | — | Filing → |